MedX Health Corp (TSXV:MDX)
Canada
· Delayed Price · Currency is CAD 0.0900
0.00 (0.00%)
Jun 27, 2025, 4:00 PM EDT
MedX Health Income Statement
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| 0.49 | 0.49 | 0.46 | 0.51 | 0.56 | 0.53 | Upgrade
| |
Revenue Growth (YoY) | -3.82% | 7.37% | -10.68% | -9.32% | 6.23% | -38.38% | Upgrade
|
Cost of Revenue | 0.28 | 0.3 | 0.27 | 0.27 | 0.29 | 0.26 | Upgrade
|
Gross Profit | 0.21 | 0.19 | 0.19 | 0.24 | 0.27 | 0.27 | Upgrade
|
Selling, General & Admin | 2.46 | 1.97 | 2.63 | 3.43 | 3.84 | 2.79 | Upgrade
|
Research & Development | 0.51 | 0.53 | 0.59 | 0.68 | 1 | 0.43 | Upgrade
|
Operating Expenses | 2.96 | 2.5 | 3.21 | 4.11 | 4.84 | 3.3 | Upgrade
|
Operating Income | -2.75 | -2.3 | -3.03 | -3.87 | -4.56 | -3.03 | Upgrade
|
Interest Expense | -1.57 | -1.35 | -2.15 | -1.27 | -0.78 | -0.06 | Upgrade
|
Currency Exchange Gain (Loss) | - | - | - | 0 | -0.01 | -0.01 | Upgrade
|
EBT Excluding Unusual Items | -4.32 | -3.65 | -5.18 | -5.13 | -5.35 | -3.1 | Upgrade
|
Gain (Loss) on Sale of Assets | - | - | 0.6 | - | - | - | Upgrade
|
Other Unusual Items | - | - | - | - | 0.02 | -0.1 | Upgrade
|
Pretax Income | -4.32 | -3.65 | -4.58 | -5.13 | -5.32 | -3.2 | Upgrade
|
Net Income | -4.32 | -3.65 | -4.58 | -5.13 | -5.32 | -3.2 | Upgrade
|
Net Income to Common | -4.32 | -3.65 | -4.58 | -5.13 | -5.32 | -3.2 | Upgrade
|
Shares Outstanding (Basic) | 269 | 267 | 197 | 184 | 180 | 167 | Upgrade
|
Shares Outstanding (Diluted) | 269 | 267 | 197 | 184 | 180 | 167 | Upgrade
|
Shares Change (YoY) | 24.50% | 35.55% | 7.09% | 1.98% | 8.18% | 18.81% | Upgrade
|
EPS (Basic) | -0.02 | -0.01 | -0.02 | -0.03 | -0.03 | -0.02 | Upgrade
|
EPS (Diluted) | -0.02 | -0.01 | -0.02 | -0.03 | -0.03 | -0.02 | Upgrade
|
Free Cash Flow | -2.54 | -2.51 | -3.42 | -2.8 | -4.53 | -2.91 | Upgrade
|
Free Cash Flow Per Share | -0.01 | -0.01 | -0.02 | -0.01 | -0.03 | -0.02 | Upgrade
|
Gross Margin | 42.50% | 39.66% | 40.70% | 46.99% | 48.54% | 50.58% | Upgrade
|
Operating Margin | -557.53% | -470.44% | -663.99% | -757.61% | -810.29% | -571.52% | Upgrade
|
Profit Margin | -875.08% | -745.96% | -1004.31% | -1005.41% | -945.40% | -603.60% | Upgrade
|
Free Cash Flow Margin | -514.68% | -512.70% | -750.32% | -548.53% | -805.04% | -549.81% | Upgrade
|
EBITDA | -2.76 | -2.3 | -3.02 | -3.86 | -4.55 | -2.99 | Upgrade
|
D&A For EBITDA | -0.01 | 0 | 0.01 | 0.01 | 0.01 | 0.04 | Upgrade
|
EBIT | -2.75 | -2.3 | -3.03 | -3.87 | -4.56 | -3.03 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.